Else Nutrition Holdings Inc (BABY) Quote

Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
7:30 AM ET 6/10/25 | Dow Jones

Else Nutrition Welcomes 3 Major Federal Developments that Could Unlock Market Access & Open the Door to the First Major Breakthrough in Infant Formula in Decades

VANCOUVER, BC, June 10, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a global leader in clean label, plant-based childhood nutrition, welcomes a recent trio of significant policy signals from the U.S. Government that could reshape the nation's infant formula landscape.

These developments - spanning FDA regulatory reform, Congressional oversight, and executive action - reflect growing national momentum to modernize outdated regulations and expand consumer choice in baby formula.

National Academy Report Supports Smarter Science, Aligns with Else's Regulatory Approach

In a move that could have broad implications for new formula entrants, the FDA commissioned a National Academy of Sciences study to examine global regulatory standards for infant formula - particularly focusing on the outdated Protein Efficiency Ratio (PER) study, which had long served as a barrier for plant-based options like Else's.

The newly released study recommends replacing the outdated PER test with modern, evidence-based alternatives that better reflect international norms and nutritional science. This marks a turning point for Else, whose regulatory strategy has been built around these same more progressive standards.

"We are encouraged by the Academy's findings and look forward to these recommendations informing forthcoming FDA guidance," said Hamutal Yitzhak, CEO & Co-Founder, Else Nutrition.

Congressional Pressure Grows for Modernized Plant-Based Infant Formula Pathway

In parallel, Else Nutrition welcomes mounting attention to infant formula policy from the United States Congress. Earlier this year, top Republican Appropriators - a Members of a powerful Committee in Congress that maintains the "Power of the Purse" - sent a formal Congressional Oversight letter to the agency, urging the FDA to create a clear, modernized regulatory pathway for plant-based infant formula that matches the international standard. Congress' intent reflects a shared perspective that the National Academy study unveiled.

This rare Congressional intervention emphasizes the urgency of reform and calls for U.S. policy to upgrade to international standards that already embrace plant-based options. It also signals the potential for future Congressional action to reinforce the need for change and hold the FDA accountable.

"Congressional Appropriators are sending a strong signal that American parents deserve safe, vetted plant-based alternatives, and that companies like Else deserve a fair, science-aligned path to market, with regulatory guidance to match," added Ms. Yitzhak.

Administration Launches 'Operation Stork Speed' to Cut Red Tape

Furthering the support is the Administration's new initiative, Operation Stork Speed, aimed at accelerating access to infant formula by streamlining regulatory processes and clearing bureaucratic roadblocks. The program is expected to fast-track FDA reforms while ensuring safety and nutritional integrity.

Else Nutrition looks forward to engaging directly with the Administration to help shape a smarter, more inclusive infant formula future.

A New Era of Opportunity for Infant Nutrition

Together, these three developments - scientific, legislative, and executive - signal a generational shift in how the U.S. regulates and supports infant nutrition. For Else Nutrition, they offer renewed confidence that the path forward is finally being cleared. This initiative is a direct complement to the Congressional attention and the National Academy study, and Else looks forward to collaborating with the Administration.

"These reforms aren't just good for Else - they're good for every parent seeking cleaner, safer, baby formula options beyond dairy," said Ms. Yitzhak. "We continually get requests from so many families in real need of finding an alternative beyond dairy-based baby formula. We're proud to be at the forefront of this movement for change and are ready to serve American families with the trusted nutrition they deserve."

Our researcher type CIO still hasn't figure out that she has been the problem all the way thru this other year. Because of her stobboness to try to run an operation she doesn't understand, he's heading right into a bancrupcy unless she finds competent help ... assuming she can even understand she need thad badly. I do not hold my breath.

Press Release: Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
1:12 PM ET 6/2/25 | Dow Jones

Conference call to be held Tuesday, June 3(rd) at 10:00 AM Eastern Time

VANCOUVER, BC, June 2, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), reported financial results for the 2024 fiscal year ended December 31, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile.

"2024 was a defining year for Else Nutrition, marked by significant challenges that ultimately led to pivotal decisions shaping our future," commented Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "While we encountered major headwinds, including funding constraints, inventory shortages, and a limited marketing budget, we took decisive actions to secure our future. Specifically, we optimized operations, significantly reduced overhead costs, and secured essential funding. We also streamlined our cost structure by cutting underperforming roles, reducing low-ROI marketing spend, and exiting unprofitable retail partnerships. In addition, we restructured R&D operations, including the closure of our Israel lab, to preserve innovation capacity while improving financial performance. Furthermore, we plan to expand our manufacturing and prepare our powder formula in Europe, which will lower production costs, improve margins, and enhance product quality."

"Despite our challenges, we made important progress including successfully launching our first Adult Ready-to-Drink (RTD) product, expanding retail placement for our Kids RTD product, and increasing our presence in the U.S. through e-commerce platforms. These milestones reflect the growing demand for plant-based, allergen-friendly nutrition, and we intend to capitalize on these opportunities."

"On the regulatory front, we are encouraged by the FDA and HHS's launch of Operation Stork Speed, an initiative aimed at expanding infant formula options and strengthening supply chain resilience. Through our continued bipartisan advocacy efforts, we aim to make significant progress toward modernizing FDA guidelines for plant-based, non-soy, non-dairy infant formula. We look forward to working closely with regulators to establish a clear pathway, ensuring that parents have access to safe, high-quality, and scientifically backed nutrition alternatives."

"Furthermore, we were recently featured in an op-ed published in The Washington Times, titled "Operation Stork Speed will ensure babies get the nutrition they need." The piece highlights the importance of accelerating access to clean-label, plant-based alternatives and aligns with our broader mission and ongoing advocacy efforts in Washington to promote science-backed updates to infant nutrition guidelines."

"Looking ahead to 2025, we are focused on expanding our retail distribution, scaling our European production, and enhancing brand visibility through targeted marketing and strategic partnerships. With a solid foundation in place, Else Nutrition is well-positioned for long-term growth, and we remain committed to delivering clean-label, plant-based nutrition solutions that meet the needs of families worldwide."

2024 Fiscal Year Financial Results

All figures are in CAD unless otherwise indicated.
-- Revenue for 2024 decreased approximately 14.8% to $8 million compared to
$9.4 million for 2023.

-- Operating expenses for 2024 was $13.6 million, a decrease of 20% compared
to $16.9 million for 2023

-- Cash balance as of December 31, 2024, was $0.3 million (including
restricted cash).

Conference Call

Else Nutrition management plans to host a business update conference call Tuesday, June 3(rd) at 10:00 a.m. Eastern Time to discuss the Company's financial results for the 2024 fiscal year ended December 31, 2024, as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1-877-407-9219 for U.S. callers or +1-412-652-1274 for international callers. A webcast of the call may be accessed at https://event.choruscall.com/mediaframe/webcast.html?webcastid=vDEyPa8B or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.

A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through June 3, 2026. A telephone replay of the call will be available approximately three hours following the call, through June 17, 2025, and can be accessed by dialing 1-877-660-6853 for U.S. callers or +1-201-612-7415 for international callers and entering conference ID: 13754118.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Bab

BABYF is off something over 99+% since I began following this POS several years ago. Why did I follow it? Because I spotted it immediately as floorless, moat-less rubbish. Uniquely awful in several way.

Of course, I never bought any BABYF. My kids have large cap blue chips and index funds. Audited dividend payers.

If I have to go that far, my wife will get rid of what she call garbage stocvks (LOL)

pual, leave shares to grandkids and perhaps they'll reap the rewards > if any.

I enjoy following 2 small stocks of companies I betted on and traded years ago (getting my unit cost very negligeable). Both try to market great PRODUCTS/SERVICES but up to now, they are not having the success one should have expected out of them. In both case the founding CEO's are dedicated to be THE OWNER of their companies (majority shareholders) and both run the risk to run of of time because they miss ONE OF THE CRITICAL SUCCESS FACTORS (CSF) making companies succesful. One is a MARKETING DISASTER and the other one is a FINANCIALS MESS. They still can both succeed (otherwise I would have sold out) but both can go bancrupt unless they can stop being a one man/woman show. I therefore have a minimal exposure if they fail but a tremendous gain to get if they pull out of their mess before I die. FUTURE WILL TELL (LOL)

''Urgent Need for Infant Formula Alternatives'' ... according to who ?

''we look forward to continuing to collaborate with the White House, policymakers, and the FDA as we look to bring our unique solution to market in a swift and responsible manner."
Nothing wrong with that BUT ... She urgently needs help in MARKETING. She may be (is?) a GENIUS in the SCIENCES REQUIRED IN DEVELOPPING PRODUCTS but she has proven for years now that she is INCOMPETENT in the ART OF MARKETING.
She left her previous job in a very successful company not giving enough attention to ''scientific product developper'' and thereafter created a company focussed on product development but neglecting the art of marketing altogerther.
I cannot understand why she still stubornly refuses to see that this attitude made her a market failure for years.
I hope someone convince her to figure out what she keeps refuses to understand and accept.
SUCCESS REQUIRES BOTH MARKETING AND SCIENTIFIC SKILLS WORKING AS A TEAM (Having both skills in the same person is very exceptional and our CEO hasn't been granted this rare set of skills.
THE QUESTION: Will she accept that thruth or keep going till she fails for good ???

(PR) Else Nutrition CEO Highlights Urgent Need for Infant Formula Alternatives in The Washington Times Op-Ed
7:30 AM ET 5/28/25 | PR Newswire

VANCOUVER, BC, May 28, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) ("Else" or the "Company"), a pioneer in wholefood, Plant-Based nutrition for babies, toddlers, children and adults, is pleased to announce that its CEO and Co-Founder, Hamutal Yitzhak, authored a featured op-ed published in The Washington Times on May 25, 2025. Titled "Operation Stork Speed will ensure babies get the nutrition they need," the piece highlights the urgent need to modernize the infant formula regulatory environment and emphasizes the importance of increasing access to safe and innovative nutrition options--particularly for infants with dietary restrictions or allergen sensitivities. The Washington Times has a substantial readership in Washington, D.C., particularly among Congress and the Administration.

"Our mission has always been to deliver a safe, plant-based infant formula that supports healthy development and gives families--especially those with dietary or dairy/soy allergen concerns--greater access to trusted nutrition," said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. "Operation Stork Speed is an excellent initiative designed to expand access to these types of formulas, and as noted in the Washington Times op-ed, we look forward to continuing to collaborate with the White House, policymakers, and the FDA as we look to bring our unique solution to market in a swift and responsible manner."

Regulatory Pathway and Status

Else Nutrition has developed a clean-label, whole plant-based infant formula intended as an alternative to dairy- and soy-based products. In 2023, the Company successfully concluded the pre-clinical studies required and received Institutional Review Board (IRB) approval for its infant growth clinical study protocol--marking a key step toward U.S. Food and Drug Administration (FDA) compliance. At present, the Company is awaiting final authorization from the FDA to initiate its clinical trial in the United States, pending regulatory modernization that the company believes may be accelerated through Operation Stork Speed. Several Congressional Appropriators recently called on the FDA to accelerate this effort, as directed through an oversight letter.

Policy Advocacy and Operation Stork Speed

The op-ed coincides with the recent launch of Operation Stork Speed, an initiative by the Trump administration and Health and Human Services Secretary Robert F. Kennedy Jr., aimed at improving the regulatory review and safety of infant formula in the United States as well as encouraging innovation and transparency in formula composition to serve unmet needs. Ms. Yitzhak's commentary lends industry perspective to this national conversation and urges regulatory authorities to accelerate the path to market for scientifically supported, non-traditional formula options.

Else Nutrition is actively engaged in this effort through direct outreach to policymakers, bipartisan advocacy on Capitol Hill, and consumer education. The Company continues to advocate for updated infant formula guidelines that recognize the validity and safety of plant-based, non-soy, allergen-friendly alternatives.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food an

Yes our problem (according to our CEO) was and still is the lack of shelves to store our procuct inventories. The fact that no one knows what is in these boxes is not an issue, everyone knows that doing her shopping, a mother of a baby does enjoy reading texts printed on boxes she never even noticed before. That renders our CEO ''Thrilled'' ???

Else Nutrition Expands Nationwide with Kids Ready-to-Drink Shakes in 1,000 Leading U.S. Retailer Stores
7:30 AM ET 5/27/25 | Dow Jones

VANCOUVER, BC, May 27, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a leader in plant-based nutrition for early life and adult nutrition, is excited to announce its expanded footprint in the U.S. retail market with the launch of its Ready-to-Drink (RTD) products in a leading grocery retail chain. Starting May 2025, Else's clean-label Kids RTD products are available in 1,000 stores nationwide.

Launched in 2024, Else's ready-to-drink kids' shakes quickly gained traction among parents seeking nutritious, dairy-free, and soy-free options for their children.

"We are thrilled to see our RTD line gain a prominent spot on the shelves of this retail giant," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This milestone demonstrates the strength of the Kids RTD category and the increasing consumer demand for clean-label, plant-based options. Kids don't need another ultra-processed drink, and our minimally processed ingredients-based shakes are the only whole-food-based option that both parents and kids love."

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com

Never before (multi decades of experience) did I see a company having that level of potential (5 years ago) been that much mismanaged by an executive stupid enough to keep digging a hole she was getting into. Fortunately I traded early when the stock was swingning up and down daily (Net cost thereafter minimal) but I anyhow lost somewhat (nothing important however). What is frustrating is not the lost money but the destruction of a great opportunity by incompetence and mismanagement.

They manufacture somewhere in Ohio last I checked.
They did at one time mention opening a mfgr plant in Oregon.
I dk if that ever happened.

Cannot find info if Elise will also face Tariff issues,

May be she did, maybe she did not ... We may never know because her incompetence will have make the company fail. Bosh ... you win some, you lose some ... Selling the remaining shares at that pps would be ridiculous ...

Thanks for the post.

Bottom line I think is..... she doesn't have anything special here. 🤣

Let's not forget that the market these products are in is not incredibly large either. You are looking for a person who has a child, wants no diary or soy, the child tolerates the taste, and parents can afford these products. It's a niche market.

As you are aware, there are numerous vendors in the infant formula market. Always creating new products.

Take a look at this published paper recently (2025):

A Novel Infant Formula with Medium- and Long-Chain Triacylglycerols and sn-2 Palmitate Supports Adequate Growth and Lipid Absorption in Healthy Term Infants
https://www.mdpi.com/2072-6643/17/9/1401

Medium- and long-chain triacylglycerols (MLCTs) and sn-2 palmitate constitute approximately 70~80% of total breast milk fat. The structured lipid MLCTs and sn-2 palmitate, mimicking human milk, have demonstrated improvement in lipid absorption and energy metabolism in vitro and in animal experiments

Also, we can compare the difference in revenue in diary milk vs. all other "milk" alternatives for adults and see that the latter doesn't compare very much.

The average weekly sales of all dairy and plant-based milk products over the 2018-2022 years are $290 million. Average weekly sales of regular dairy milk are $219 million/week, accounting for the largest share of this category at 75.6% (Figure 1).

https://ag.purdue.edu/cfdas/wp-content/uploads/2023/07/An-Analysis-of-U.S.-Dairy-and-Non-Dairy-Milk-Demand_USB-approval_6-29-update.pdf

Changing the perception of people through thousands of years of drinking milk is one heck of a challenge.

With all that said, I have a hard time believing that she does not understand marketing a product. Even the most basic entrepreneur understands this.

Is she really not smart enough to grasp this? Is she really not smart enough to hire a firm to help her? Or a person with knowledge?

It seems way too unrealistic.

In all honesty, Tesla doesn't do advertising in the traditional sense and has no marketing budget. 🤣

Maybe it's just her way of doing business as well. Word of mouth. 🤣

THE ESSENCE OF THIS PR: Else needs access to more SHELVES

This new PR once more demonstrate the total incompetence of our CEO (At least in managing the company).
She effectively may be a great product conceptor and developer but she doesn’t have any idea of what is required to have products on shelves BOUGHT BY CONSUMERS.

Notwithstanding the disastrous past 5 years or so, once again our ridiculous CEO demonstrates that her belief is still that OUR PROBLEM is LACK OF AVAILABILITY OF SHELVES to store our products on. She writes: ‘’With public support and FDA cooperation, the Company can ‘’Bring its formula to american SHELVES’’. She adds: ‘’Modernizing regulatory pathways is the crucial next step so the Company can Bring its formula to American SHELVES’’.

HISTORY
4,5 years ago (2020-12-09) our share were selling at $4,26.
Since then, AFTER ADDING THOUSANDS OF SHELVES to stock our boxes on, it trades at $0,015 a 97% drop.

QUESTION
Can anyone explain to her that having access to more shells is not her problem but HAVING POTENTIAL CUSTOMERS BUY THE PRODUCT OFF THE SHELVES is the urgent priority that must be addressed ? Would be nice if someone was to inform the market of what is in these anonymous boxes !!!

It is my opinion based on facts and experience. Having time to lose today, let me prove it ...

After 5 years of believing that putting boxes on shelves will automatically make prospect to change their habits without knowing what these new boxes are all about was dumb and a demonstrated belief of our CEO (I said it in here for years).
The Executive team our CEO built was qualified to operate Lab, technical or research and even the one she made in charge of ‘’business development in a very specific competitive market ‘’previously was Chief technology officer''. I have a lot of respect for that experience but in no way does it qualify him to develop a market for a product attacking a market already occupied by some large international successfull competitors with years and years of experience.
Our CEO wasn’t smart enough (or was stubborn enough) to not accept that INVESTING IN MARKETING was effectively not an EXPENSE but an INVESTMENT, a concept she obviously did not understand even when failure was obvious.
The team she built shows she did not believe in the importance of Marketing.

Founders
Hamutal Yitzhak : Former Abbott Laboratories
Michael Azar : Chief Executive Officer at Materna Laboratories Ltd.
Uriel Kesler : Golden Heart FMCG Ltd. … Household, Appliances, Electrical and Electronic Goods

Management
Shay Shamir : worked as a Senior Auditor at Ernst & Young (Israel) Ltd
Dr. Fabiana Bar Yoseph : Director of Infant Nutrition Research & Development, Enzymotec Ltd
Renana Mizrahi : Hebrew University of Jerusalem B. Sc. Nut, Clinical Nutrition/Nutritionist
Avi Markus: innovator and leader in the Natural Food & Beverage space
Reuben Halevi : Chief Technology Officer at MIND C.T.I. Ltd. from 2018 to 2019.

Our CEO definitely was believing all along that : ‘’ If you have a great product it will sell automatically’’. More than 5 years later she still behaves as if she wasn’t able to accept she was wrong all along.
Marketing/sales go hand in hand with Product quality and one without the other leads to failure.
proven
This is more than an opinion ... it’s a proven fact and has been so for decades in many cases and industries, particularly in the case of startup like companies trying to penetrate new markets.

(PR) Else Nutrition Launches 'Formula for Change' Campaign, Building on Momentum from Operation Stork Speed to Deliver Real Choice for American Families
7:00 AM ET 4/23/25 | PR Newswire

Else Nutrition Launches 'Formula for Change' Campaign, Building on Momentum from Operation Stork Speed to Deliver Real Choice for American Families

PR Newswire

VANCOUVER, BC, April 23, 2025

A Bold Step Toward Inclusion: Else Nutrition Aims to Deliver a Real Alternative for Millions of Babies Who Can't Tolerate Dairy-Based Formula

VANCOUVER, BC, April 23, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), a global leader in clean-label, plant-based childhood nutrition, is launching a bold new advocacy campaign--'Formula for Change'--to accelerate U.S. regulatory support for clinical trials of its breakthrough dairy-free, soy-free infant formula.

This initiative builds on the positive momentum of Operation Stork Speed, a recent federal effort to fast-track next-generation infant formula development. Else Nutrition applauds this long-overdue modernization effort and urges the FDA to take the next step by opening innovative regulatory pathways for clinical trials of Else's infant formula. This will help ensure American families finally gain access to a safe, inclusive, and science-backed alternative to traditional dairy-based formulas.

"We're inspired by Operation Stork Speed," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "It signals a shift toward innovation and inclusivity in infant nutrition. Now we're calling on the FDA and U.S. representatives to act on this progress and greenlight clinical trials that will allow us to bring our transformational option to families who've waited too long."

The First Real Innovation in a Generation

For decades, U.S. parents have had just two options: dairy or soy. But countless babies are unable to tolerate either. Families making plant-based lifestyle choices have similarly been left without viable options. Else Nutrition has developed the world's first infant formula based on whole plant ingredients, including almonds and buckwheat--free from dairy, soy, and ultra-processed ingredients. Already gaining international traction, the formula mirrors the nutritional benefits and profile of human milk and holds the Clean Label Project Purity Award for exceptional safety.

Pushing Forward with Progress - Not Hitting a Wall

While the product is already available abroad, outdated U.S. regulations currently prevent Else from initiating clinical trials required for infant formula approval. The Company sees Operation Stork Speed as a meaningful foundation to modernize these outdated systems and believes the time is ripe for inclusion of Plant-Based innovation in these efforts.

"We've already heard from thousands of U.S. families about how our toddler formula changed their children's lives," said Yitzhak. "Operation Stork Speed gives us hope--but hope needs action. Modernizing regulatory pathways is the crucial next step to enable innovation for the babies who need it most."

Why Else Nutrition Supports Operation Stork Speed

Else Nutrition is actively seeking inclusion in Operation Stork Speed to help close a dangerous gap in infant nutrition:
-- U.S. regulations lag behind Europe, Canada, and Australia.

-- Many U.S. formulas contain toxic metals or synthetic additives.

-- Four companies control the market, creating vulnerability and limiting
innovation.

-- The 2022--2023 formula shortage crisis exposed deep systemic weaknesses.

Operation Stork Speed seeks to address these issues by encouraging innovation--and Else's formula represents exactly the kind of science-driven, next-generation product this program is designed to support.

Join the Movement: Demand Real Choice

Else Nutrition is mobilizing parents, pediatric professionals, and policymakers to advocate for inclusive, evidence-based nutrition. With public support and FDA cooperation, the Company can launch clinical trials and bring its formula to American shelves.

Here's how you can help drive the Formula for Change:
1. Email your Member of Congress to urge FDA action on modern regulatory
pathways.

2. Sign the petition on Change.org to amplify the public voice.

3. Pledge your support--$25, $50, or $100--to help Else advance clinical
readiness.

Learn more and take action today: https://elsenutrition.com/pages/realchoice

DISCLAIMERS

This grassroots lobbying effort is a statement of issue advocacy and does not require disclosure under the Lobbying Disclosure Act. This is not an electioneering statement, and this message has not been coordinated with any political parties or candidates. This message is paid for by Else Nutrition and is intended for only a "restricted class" of stockholders and administrators of the company. Whereas this is an instance of grassroots lobbying, Else Nutrition's engaged lobbying principals file disclosures required under the Lobbying Disclosure Act for direct lobbying services on behalf of the company.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards

she has minimized the value of good marketeers

That will do it.

and therefore tought it was spending money for no added value for the team.

Is this just your opinion or is this fact? Like she came out and said, "spending money on marketing has no added value?"

Or are you extrapolating from the information in the reports with this company?

It just seems odd that someone doesn't understand that marketing is beneficial. Products don't sell themselves at first. It needs a little help.

I think there's more to the story here.

''It’s only late if she doesn’t see her problem.''
Like many she has minimized the value of good marketeers and therefore tought it was spending money for no added value for the team.
Many failures came from that believe. Perfect example was the Beta technology (Very much better technology) losing to VHS because Japaneese (Fantastic manufacturers) also did not have access to a good understanding of the markets they were getting involved in.
The difference between the the Japaneese and our CEO is that Japaneeses learned from their failure (Thereafter generally using partners bringning them skills they did not have but but needed).

But why is she incompetent when it came to the business? What specifically?

Did she not know how to market her products? Was the formulas not a hit? Did she not know how to scale her products? Did she not know how to innovate when consumers didn’t like the product? Did she not know how to pivot when consumers didn’t want her products?

It’s a bit strange that a person can create formulas in a methodological way but not see that her business is nearing bankruptcy.

Unfortunately, a great scientist doesn’t always (probably even more so) equate to business acumen.

Why is it to late? It’s only late if she doesn’t see her problem.

BABYF is a simple mixture of "Almonds, Buckwheat, and Tapioca." Like it? Make it in your own kitchen.

What went wrong is that a competent scientist tought she could manage a company not being competent enough to do it.
Where she made a fool of herself is when she did not reach for help seeing her company was regularly moving toward bancruptcy.
It's now to late and time has come to finally write it off (if not yet done).

I can't believe this company's stock is sub-penny? That's wild.

I remember when it was in the dollars. Something clearly went wrong here.

Not really a surprise. The executives of the company have lost control of their operations and are incompetent. The only remaining question (I assume they are not yet at risk to go bancrupt) is how much would another company accept to pay to acquire whatever assets the company has ? The darn CEO has and still destoy(ed) the company by her incompetence and financing herself thru issuance of new shares. A stubborn incompetent CEO cannot succeed.

(PR) ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER
8:49 PM ET 4/1/25 | PR Newswire

ELSE NUTRITION GRANTED VOLUNTARY MANAGEMENT CEASE TRADE ORDER

PR Newswire

VANCOUVER, BC, April 1, 2025

VANCOUVER, BC, April 1, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") announces that it has been granted a voluntary management cease trade order in accordance with National Policy 12-203 due to it not being able to file its annual financial statements, management's discussion and analysis ("MD&A") and annual information form ("AIF") for the year ended December 31, 2024 on SEDAR within 90 days of its financial year-end. The management cease trade order has been granted by the Company's principal regulator, the British Columbia Securities Commission.

The Company concluded that it would not be in a position to complete the year-end audit within the time periods required by National Instrument 51-102 due to timing constraints in completing audit procedures. As a result, the Company requires additional time to file its annual financial statements, MD&A and AIF for the financial year ended December 31, 2024.

The Company expects to file its annual financial statements, MD&A and AIF for the year ended December 31, 2024 by April 9, 2025 and in any event no later than May 30, 2025, and will issue a news release once they have been filed. The Company intends to satisfy the provisions of the alternative information guidelines of National Policy 12-203, by issuing bi-weekly default status reports, in the form of news releases, until the revocation of the management cease trade order. The Company is not subject to any insolvency proceedings. The management cease trade order will prohibit the chief executive officer and the chief financial officer of the Company from trading in securities of the Company for so long as the annual financial statements, MD&A and AIF are not filed. The issuance of the management cease trade order does not affect the ability of persons other than the chief executive officer and the chief financial officer of the Company to trade in the Company's securities.

About Else Nutrition Holdings Inc.

Thanks but honestly, the woman is so stubborn and stupid she still will not do what has to be done. She is allergic to marketing. For the moment she keeps financing herself by diluting us. To bad the pps doesn't even allow to walk away from this garbage.

Else Nutrition Schedules 2024 Fiscal Year Business Update Conference Call
7:00 AM ET 3/21/25 | Dow Jones

Else Nutrition Schedules 2024 Fiscal Year Business Update Conference Call

Canada NewsWire

VANCOUVER, BC, March 21, 2025

VANCOUVER, BC, March 21, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 10:00 a.m. Eastern Time on March 31, 2025 to discuss the Company's financial results for the 2024 fiscal year ended December 31, 2024, as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1-877-407-9219 for U.S. callers or +1-201-689-8852 for international callers. A webcast of the call may be accessed at https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEF3gH7K or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.

A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through March 31, 2026. A telephone replay of the call will be available approximately three hours following the call, through April 14, 2025, and can be accessed by dialing 1-877-660-6853 for U.S. callers or +1-201-612-7415 for international callers and entering conference ID: 13752367.

Interested parties who would like to submit a question to be addressed on the call can email the question to baby@crescendo-ir.com.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is

pual, right on!

Held my nose and picked up some for LT potential.

That is a GREAT OPPORTUNITY offered to Else by the government. This being said, Else must now inform the public of their offering but we know our CEO is not qualified to do any type of serious marketing. I hope she will wakeup and do what has to be done instead of, as usual, do nothing but hope parents will find our offerings all by themselves.
The reason I doubt she will do what has to be done is that she is allergic to anything that even sound like ''MARKETING''. If she does not rapidly (days) hire (investment) a marketing executive (she sees that as an expense) able to exploit this new opportunity, we will again look at the market skip our shelves to buy something less interesting but better known.. Let's see if she finally stop being a stubborn researcher anti marketing INVESTMENT

Else Nutrition Commends HHS & FDA's Operation Stork Speed on Expanding Infant Formula Options

PR Newswire

VANCOUVER, BC, March 20, 2025

HHS/FDA Announcement Bolsters Else Nutrition's Momentum in Bringing its Infant Formula to Market in the United States

VANCOUVER, BC, March 20, 2025 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), applauds the leadership of Secretary Robert F. Kennedy in launching Operation Stork Speed, a strategic initiative by the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) aimed at expanding infant formula options. This effort demonstrates the importance of nutritional adequacy and supply chain resilience while facilitating the development of new infant formulas within the United States.

As part of its commitment to bringing the first whole food, minimally processed, clean-label, plant-based infant formula to American families, Else Nutrition has been actively engaged in a robust Washington D.C. effort through its U.S. office. This includes hiring a leading healthcare lobbying firm, conducting bipartisan Congressional meetings across both chambers, and preparing to launch a grassroots lobbying program. To date, this effort has resulted in significant Congressional oversight on modernized FDA guidance on plant-based, non-soy, non-dairy infant formula options--an essential step for Else Nutrition to conduct key clinical trials in the U.S.

In January 2025, the FDA released their Long-Term National Strategy to Increase the Resiliency of the U.S. Infant Formula Market, which followed the National Academies of Sciences, Engineering, and Medicine also recently convening a study on these issues. This week's announcement of Operation Stork Speed is another significant step from HHS in ensuring access to safe, high quality infant formulas.

"At Else Nutrition, we are dedicated to ensuring that families across America have access to safe, high-quality, minimally processed plant-based nutrition options," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "Many infants with medical, dietary or dietary needs require such formulas. Congress has taken significant action to ensure access to these formulas and we are pleased to see the Administration continue this most important work. We applaud President Trump and Secretary Robert F. Kennedy for their leadership in launching Operation Stork Speed and look forward to collaborating with HHS and the FDA to create a modernized regulatory pathway for plant-based, non-soy, non-dairy infant formulas. By combining rigorous science with the power of natural ingredients like almonds, buckwheat, and tapioca, we are redefining early childhood nutrition to be healthier, more sustainable, and more accessible to parents seeking clean-label alternatives."

About Else Nutrition Holdings Inc.

Apparently ... I hope he does watch the woman because she is so incompetent she may see urgency in developping new products ???

LOLOLOL. Hardly. Borrows are often fully backed with cheap Reg S conv stock that can be dumped into the market quickly. You may be a dumb penny player, but the lenders aren't.

"Apparently there is a lender convinced they will survive."

Apparently there is a lender convinced they will survive.

Till the incompetent stupid woman gives up (do not hold your breath) this will remain a desastrous investment. The woman is stubborn up to ending up bancrupt before she accept that she is destroying her toy. To bad ... She had an opportunity and did destroy it by being stupid.

No wonder it keeps dropping.
"Else Nutrition expects to use the proceeds for general working capital." in other words, pay raises perhaps.


Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.

The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.

Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.

Else Nutrition expects to use the proceeds for general working capital.

Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.

Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.

Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.

The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.

Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.

Else Nutrition expects to use the proceeds for general working capital.

Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.

Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.

All our CEO cares about is ''PRODUCTS'' charasteristics. I do not care how many products she now has or will develop, till she or someone can MARKETING THEM, our shares will remain worthless.
Unfortunately, our CEO is alergic at marketing, considers that to be a useless expense and will keep issuing PR's aimed at shareholders.
What a mess that incompetent CEO has been and is making out of a great opportunity.

Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes
7:00 AM ET 1/21/25 | Dow Jones

Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes

Canada NewsWire

VANCOUVER, BC, Jan. 21, 2025

The U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products

VANCOUVER, BC, Jan. 21, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), a leader in clean, Plant-Based nutrition, announces its entry into the adult food market with the launch of its revolutionary ready-to-drink (RTD) nutritional shakes for adults in the U.S. and Canada.

As the first and only whole-food, plant-powered, complete nutrition drink for adults, Else Nutrition's RTD shakes are poised to redefine the adult nutritional beverage market. Notably, the U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products. Furthermore, 44% of flexitarians cite health benefits as a key driver in choosing plant-based options. Else Nutrition's RTD shakes meet this growing demand, offering a superior product that aligns with vegan, vegetarian, and flexitarian dietary preferences.

As more consumers embrace plant-based diets and seek sustainable, clean-label products, Else Nutrition's Adult RTD shakes offer a timely and innovative solution. Made from real, whole-food ingredients like almond butter, sunflower protein flour, and buckwheat flour, these dairy-free, minimally processed shakes provide a nutritious, easy-to-digest alternative to traditional dairy-based nutritional supplements.

A Complete Nutritional Solution

Each serving of Else Nutrition's RTD shake provides:
-- 280 calories and 14g of high-quality plant protein

-- Natural fiber, healthy carbohydrates, and unsaturated fats

-- 26 essential vitamins and minerals tailored to adults' health needs

-- 50% less sugar than leading competitors with no artificial sweeteners

-- Lactose-free, cholesterol-free, low in saturated fat, and Clean Label
Project Certified

Else Nutrition's RTD Vanilla shakes are now available in Canada in 8 fl. oz. (236 mL) tetra packs, offered in 6-packs and 24-packs. They can be purchased on Amazon.ca and at select retail locations. Additional flavors are planned for future release. In the U.S., the product line is set to launch in Q2 2025.

"We are proud to introduce a convenient, clean, and delicious option for adults looking to meet their daily nutritional needs," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This launch is a natural progression of our mission to deliver whole-food-based nutrition for all ages. Our adult shakes aren't just better for you and easier to digest--they're better for the planet."

To delve deeper into Else Nutrition's offerings and its revolutionary approach to nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and whole Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category

-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo

-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category

Thia (and another little one) are toys to play with using money I ca afford to lose. However to be honest, initially (bought at $0,38) I tought Baby was an opportunity and for a while I did enjoy trading it so I got more shares and kept a very low net cost. I however did not know the CEO was annything but a serious tecky with no competence whatsoever in managing a good company. Over and above being incompetent in business managing she also demonstrated she was stupidly stubborn, refusing to see what was happening. I therefore lose my initial investment that became a ''BET'' and am sorry to conclude that I found out to late that our CEO was outright incompetent. In penny stock, you lose some, you win some ... Baby revealed to be an opportunity destroyed by incompetence.

Is it going to fall ANOTHER 24%? With troubled, low quality stocks the best time to sell is NOW. Or best, never buy in the first place which is my method (I only buy large cap exchange-listed blue chips or high quality funds. And I always study and understand the audits.

That would be the death kiss.

tax selling next week will probably see 5-10 million share days.

R/S?????

I agree but with her ???

I don't think she will bankrupt the company but find a buyer

Innovative??? "Gee, a mix of almonds, buckwheat, and tapioca."